Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

April 8, 2024 Cover

Volume 102, Issue 11

Can they fix the bottlenecks in elder care?

Full Article
Volume 102 | Issue 11

All Issues

Quote of the Week

“We appear to be in mud up to the axle, so it’s been tough.”

Walt Hart, olefins Americas lead, S&P Global Commodity Insights

  • The rise of subscription-based AI platforms for drug discovery

    Claiming a democratization of the field, companies are increasingly offering AI-based services to a wider audience

  • Verve pauses gene therapy trial, switches delivery agent

    Adverse effects show that LNP choice is tricky, despite the technology’s success in COVID-19 vaccines

  • Cyclodextrins, reflected

    Mirror-image sugar rings sweeten supramolecular chemistry

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT